Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - improve drift control | improve pesticide deposition | reduce alkaline hydrolysis | wetting agent (use as directed) | improve penetrating properties | improves chemical uptake | improves droplet deposition

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - agricultural chemical additive | herbicide additive | wetting agent | activator | penetrant | post emergent herbicide | spray ac - reduce alkaline hydrolysis | tank mixing | wetting agent (use as directed) | additive | agricultural chemical | herbicide | improve penetrating properties | minimise antagonism | spray tank

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - control of penetration | reduce alkaline hydrolysis | wetting agent (use as directed) | improve penetrating properties

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm australia limited - paraffin oil - emulsifiable concentrate - paraffin oil petroleum derivative-oil active 471.0 g/l - adjuvant - agricultural chemical additive | herbicide additive | activator | penetrant | post emergent herbicide | spray activator | spread - spreader spray (refer to directions) | spreading agent | wetting agent (use as directed) | improve penetrating properties

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

momentive performance materials inc. - trisiloxane ethoxylate - liquid - trisiloxane ethoxylate emulsifiers & surfactants-noni active 500.0 g/l - adjuvant - foliar nutrients additive | fungicide additive | growth regulator additive | insecticide additive | low volume application | ret - carrier - anti-evaporant | horticultural tree crops | spreading agent | vegetable - refer to label | vines - refer to label | wetting agent (use as directed) | adjuvant | apples | avocadoes | citrus | evaporant | herbicide application | improve penetrating properties | insecticide application | mangoes | olives | wetter

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - non-ionic surfactants mixture; paraffinic oil - emulsifiable concentrate - non-ionic surfactants mixture emulsifiers & surfactants active 210.0 g/l; paraffinic oil petroleum derivative-oil active 598.0 g/l - adjuvant - aerial spraying | broadacre cropping including fallow | cereal crop | cotton | horticultural crop | legume | spot spraying | sug - additive - refer to label | defoliation of cotton plants | defoliation aid

Австралія - англійська - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - paraffinic oil; non-ionic surfactant - oil miscible liquid - paraffinic oil petroleum derivative-oil active 598.0 g/l; non-ionic surfactant emulsifiers & surfactants-noni other 210.0 g/l - wetting agent - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - spreader spray (refer to directions) | wetting agent (use as directed) | improve penetrating properties

Ізраїль - англійська - Ministry of Health

bayer israel ltd - loratadine; pseudoephedrine sulfate - tablets prolonged release - loratadine 5 mg; pseudoephedrine sulfate 120 mg - loratadine - loratadine - relief of symptoms of seasonal allergic rhinitis when both the antihistaminic properties and the nasal decongestant activity are desired.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - methylphenidate hydrochloride, quantity: 60 mg - capsule, modified release - excipient ingredients: purified talc; methacrylic acid copolymer; ammonio methacrylate copolymer; triethyl citrate; iron oxide yellow; gelatin; macrogol 6000; titanium dioxide; iron oxide black; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; ethanol absolute; potassium hydroxide; maize starch; sucrose - ritalin 10 tablets and ritalin la capsules are indicated for the treatment of adhd. ritalin 10 tablets are also indicated for the treatment of narcolepsy. attention-deficit hyperactivity disorder (adhd) adhd was previously known as attention-deficit disorder. other terms used to describe this behavioural syndrome include: minimal brain dysfunction in children, hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction and psycho-organic syndrome of children. ritalin 10 / ritalin la are indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. special diagnostic considerations for adhd in children: the aetiology of this syndrome is unknown and there is no single diagnostic test. adequate diagnosis requires the use, not only of medical, but also of psychological, educational and social resources. characteristics commonly reported include: chronic history of short attention span, distractibility, emotional lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and an abnormal eeg. learning may or may not be impaired. the diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of one or more of these characteristics. drug treatment is not indicated for all children with this syndrome. stimulants are not intended for use in children who exhibit symptoms secondary to environmental factors (e.g. child abuse in particular) or primary psychiatric disorders. appropriate educational placement is essential and psychosocial intervention is generally necessary. when remedial measures alone are insufficient, the decision to prescribe stimulant medicine will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. continuation of treatment in adolescent and special diagnostic considerations for adhd in adults: there is limited information to guide clinicians about how long older adolescents should continue to receive treatment with drugs for attention deficit hyperactivity disorder (adhd). the decision should be based on the extent to which symptoms of adhd and social functioning have improved to a point that medication is no longer needed. if older adolescents have been largely symptom-free for a year and are functioning well, a trial without medication is warranted. this should be undertaken at times of low stress such as during holidays or in a period when a school routine is well established. adhd needs to be considered in adults who present with longstanding symptoms suggestive of adhd (inattention, impulsivity, disorganisation) that appear to have started in childhood and are persisting into adult life. further, people with personality disorder and/or problems with drug use accompanied by a significant level of impulsivity and inattention should be referred for evaluation by a psychiatrist with the training and skills required to assess and treat adhd. this expertise is necessary due to the overlap of adhd symptoms with anxiety, mood and personality disorders. narcolepsy the symptoms include daytime sleepiness, inappropriate sleep episodes and rapidly occurring loss of voluntary muscle tone. ritalin 10 is effective for symptoms of sleepiness but not for loss of voluntary muscle tone.

США - англійська - NLM (National Library of Medicine)

l'oreal usa products inc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - avobenzone 30 mg in 1 ml - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun on damaged or broken skin rash occurs